The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections
Eliminating diarrheal diseases as a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs) will require multiple intervention strategies. In this review, we spotlight a series of preclinical studies investigating the potential of orally administered monoclonal...
Saved in:
Main Authors: | Angelene Richards (Author), Danielle Baranova (Author), Nicholas J. Mantis (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies.
by: Angelene F Richards, et al.
Published: (2020) -
Correlation of total salivary secretory immunoglobulin A (SIgA) and mutans specific SIgA in children having different caries status
by: Soumen Pal, et al.
Published: (2013) -
Leite de mulheres brasileiras apresenta anticorpos IgA secretores (SIgA) que neutralizam o rotavírus G9P[5]
by: Simone M.R. Santos, et al.
Published: (2013) -
Passive Immunity to <em>Vibrio cholerae</em> O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk
by: Danielle E. Baranova, et al.
Published: (2020) -
Role of Human Mesangial-Tubular Crosstalk in Secretory IgA-Induced IgA Nephropathy
by: Junjun Zhang, et al.
Published: (2021)